Benda Pharmaceutical, Inc (BPMA) news stock charts
Benda Pharmaceutical, Inc (BPMA/BPMA.OB) Investment Summary:
Benda Pharmaceutical, Inc. identifies, discovers, develops, and manufactures conventional medications and traditional Chinese medicines for the treatment of common ailments and diseases. Its medicines are used for the treatment of common cold, diabetes, and cancer. The company’s products include Jixuening injection vial, a haemostatic that stops bleeding; Xujing injection vial, a haemostatic; Nokeqing injection vial, Suzheng-B injection vial, Vitamin B6 injection vial, Inosine injection vial medicines used in the treatment of hepatitis; Yidingshu injection vial to treat lack of Riboflavin; Shusai-A injection vial, an anti-inflammatory analgesic; Ribavirin injection vial, and Asarin API (1), ...www.bendapharma.com
400 Employees
Founded in 2005
BENDA PHARMACEUTICAL INC (BPMA:OTC Bulletin Board Market)
LAST $0.07 USD
CHANGE TODAY +0.003 4.62%
VOLUME 557.0K
As of 8:10 PM 03/19/10 All times are local (Market data is delayed by at least 15 minutes).
Snapshot of BENDA PHARMACEUTICAL INC (BPMA)
|
OPEN
$0.07
|
PREVIOUS CLOSE
$0.07
|
|
|
DAY HIGH
$0.08
|
DAY LOW
$0.07
|
|
|
52 WEEK HIGH
10/20/09 - $0.10
|
52 WEEK LOW
07/24/09 - $0.0050
|
|
|
MARKET CAP
7.2M
|
AVERAGE VOLUME 10 D
371.4K
|
|
|
EPS TTM
$-0.09
|
SHARES OUTSTANDING
105.2M
|
|
|
BPMA Does Not Pay Dividends
|
P/E TTM
--
|
|
| K = Thousands M = Millions B = Billions | ||
Key developments for BENDA PHARMACEUTICAL INC (BPMA)
Benda Pharmaceutical, Inc Appoints Malone & Bailey, PC Replacing Kempisty & Company Certified Public Accountants, P.C., as Independent Registered Public Accounting Firm
03/3/2010
On March 1, 2010, Benda Pharmaceutical Inc. was notified that the audit practice of Kempisty & Company Certified Public Accountants, P.C., the company's independent registered public accounting firm, was combined with Malone & Bailey, PC effective as of January 1, 2010. On March 1, 2010, K&Co resigned as the independent registered public accounting firm of the company and, with the approval of the audit committee of the company's board of directors, Malone & Bailey, PC was engaged as the company's independent registered public accounting firm.
Benda Pharmaceutical, Inc announced delayed 10-Q filing
11/16/2009
On 11/16/2009, Benda Pharmaceutical, Inc announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
Benda Pharmaceutical Inc. Announces Resignation of Eric Yu as Chief Financial Officer and Executive Director
09/22/2009
Benda Pharmaceutical Inc. announced that Eric Yu submitted a letter of resignation notifying that he resigned from the position of Chief Financial Officer and Executive Director, effective September 21, 2009. Mr. Yu's resignation was due to personal reasons and not the result of any disagreement with the company or any officers or directors of the company.
Benda Pharmaceutical, Inc financial resources
BPMA Competitors
| Company | Last | Change | |
| No competitor information is available for BPMA. | |||
| Market data is delayed at least 15 minutes. | |||
Industry Analysis
| Valuation | BPMA | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 0.3x |
|
| Price/Book | 0.6x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | NM | Not Meaningful |
|
BPMA |
||
|
BPMA transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent Financial News About Benda Pharmaceutical, Inc
BENDA PHARMACEUTICAL, INC. Files SEC form 10-Q, Quarterly Report
2009-11-30 03:37:50
Quote: Read article
BENDA PHARMACEUTICAL, INC. Files SEC form 10-Q, Quarterly Report
2009-11-30 03:37:50
Quote: Read article
BENDA PHARMACEUTICAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers
2009-11-30 03:37:50
Quote: Read article
BENDA PHARMACEUTICAL, INC. Files SEC form 10-K, Annual Report
2009-11-30 03:37:50
Quote: While the Company currently believes that there is little
likelihood that actual results will differ materially from these current
estimates.
Operational Results
Year ended December 31, 2008 Compared to Year ended December 31, 2007
The following table provides key components of our operational results for the
year ended December 31, 2008 and 2007 for Benda Pharmaceutical, Inc.
Net Revenue:
The Company has five core operating segments: Benda Ebei, Jiangling Benda, Yidu
Benda, Beijing Shusai ...Read article
BENDA PHARMACEUTICAL, INC. Files SEC form 10-Q, Quarterly Report
2009-11-30 03:37:49
Quote: Read article
BENDA PHARMACEUTICAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers
2009-11-30 03:37:49
Quote: DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS;
APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.
On September 21, 2009, Eric Yu submitted a letter of resignation notifying us
that he resigned from the position of Chief Financial Officer and Executive
Director of Benda Pharmaceutical, Inc. (the "Company"), effective September 21,
2009. Mr. Yu's resignation was due to personal reasons, and not the result of
any disagreement with the ...Read article
Would you like to leave a comment about Benda Pharmaceutical, Inc BPMA/BPMA.OB
Find out what social network information about Benda Pharmaceutical, Inc are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides Benda Pharmaceutical, Inc's Stock there is more great penny stock and market information at Realpennies